=====================================================================
INFLUENZA TREATMENT AND PROPHYLAXIS OUTCOMES - WITH PARAMETER UNCERTAINTY
Date: 2025-05-12 12:47:49 (UTC)
Analysis by: michaelsegzy
=====================================================================

UNCERTAINTY METHOD: Parameter uncertainty sampling
Beta parameter range: [0.003060, 0.003740]
Tau parameter range: [0.027140, 0.033171]
Number of Monte Carlo samples: 1000

BASELINE SCENARIO
----------------
Oseltamivir 7.3% Treatment, 0.0% Prophylaxis:
Total hospitalizations: 104.7 [95.0, 115.1]

ENHANCED SCENARIOS (30% COVERAGE)
--------------------------------
Baloxavir 30.0% Treatment, 30.0% Prophylaxis:
Total hospitalizations: 81.7 [73.5, 89.7]
Percentage reduction: 21.7% [9.5%, 33.2%]

Oseltamivir 30.0% Treatment, 30.0% Prophylaxis:
Total hospitalizations: 94.0 [85.0, 103.4]
Percentage reduction: 10.0% [-4.5%, 23.6%]

ADVANCED SCENARIOS (40% COVERAGE)
--------------------------------
Baloxavir 40.0% Treatment, 40.0% Prophylaxis:
Total hospitalizations: 71.7 [64.8, 78.9]
Percentage reduction: 31.4% [20.4%, 41.7%]

Oseltamivir 40.0% Treatment, 40.0% Prophylaxis:
Total hospitalizations: 88.9 [79.9, 97.5]
Percentage reduction: 14.9% [1.6%, 27.1%]

ULTRA SCENARIOS (50% COVERAGE)
--------------------------------
Baloxavir 50.0% Treatment, 50.0% Prophylaxis:
Total hospitalizations: 62.5 [56.3, 68.9]
Percentage reduction: 40.1% [31.2%, 48.9%]

Oseltamivir 50.0% Treatment, 50.0% Prophylaxis:
Total hospitalizations: 82.9 [74.3, 91.7]
Percentage reduction: 20.6% [7.4%, 32.0%]

TRANSMISSION PARAMETERS
----------------------
R0 (Pandemic Scenario - No Intervention): 3.3472
RT (Pandemic Scenario - With 30% Intervention): 2.7897
RT (Pandemic Scenario - With 40% Intervention): 2.4068
RT (Pandemic Scenario - With 50% Intervention): 1.9505

NOTES
-----
- Values represent total seasonal hospitalizations per 100,000 population
- Square brackets show 95% confidence intervals
- Percentage reduction is relative to baseline (Oseltamivir 7.3% treatment)
- CDC data from 2017-2018 influenza season used for model validation
- Baloxavir plots shown in blue, Oseltamivir plots shown in green
- Line styles by scenario: Enhanced (solid), Advanced (dashed), Ultra (dotted)
- UNCERTAINTY METHOD: Parameter uncertainty sampling rather than output noise
